You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Novel Microfludic Device for Drug Toxicity Studies
SBC: CFD RESEARCH CORPORATION Topic: CBD10103Current drug discovery and development programs are severely limited by the expensive animal trials and oversimplified in vitro models. Results obtained from the in vitro models are not predictive of in vivo toxicity owing to significant difference in testing from the in vivo physiological conditions. In this context, we propose to develop and demonstrate a novel microfluidic device for quantitati ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
Microfluidic High-throughput Platform for Determining of Kinetic Constants of Enzyme Variants
SBC: CFD RESEARCH CORPORATION Topic: CBD10107Molecular biology techniques allow generating combinatorial libraries of large number of enzyme variants. However, there is currently no technology available for screening the enzyme libraries for identifying variants with improved activity for the substrate. We propose to develop a novel, microfluidic, high-throughput platform for determining kinetic constants of enzyme variants and identifying v ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
MEMS Lamellar Based Interferometer for the Detection of Toxic Chemicals
SBC: EPIR TECHNOLOGIES INC Topic: CBD10104In order to satisfy the DOD and commercial needs for the detection and identification of chemical warfare agents, toxic industrial chemicals or biological compounds, we propose a compact, low-cost sensor based on the integration of HgCdTe photodiode detection technology with micro-opto-electromechanical systems (MOEMS) technology, which matches HgCdTe’s sensitivity with an inexpensive microscale ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
Focal Plane Array Technology for Passive Hyperspectral Standoff Detection
SBC: EPIR TECHNOLOGIES INC Topic: CBD10105Chemical imaging sensors require focal plane arrays (FPAs) comprising long wavelength infrared (LWIR) detectors suitable for hyperspectral detection. These detectors require high sensitivity to account for the low photon counts in narrow wavelength bands. The required sensitivity elevates the associated costs, so a need exists for a lower cost LWIR FPA for use with chemical imaging sensors. The te ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
Electrochemical Screening of Multiple Enzymes Relevant to Organophosphate Poisioning
SBC: LYNNTECH INC. Topic: CBD10108Organophosphorus (OP) compounds have been extensively used as pesticides and chemical warfare agents . Potential OPs exposure exists both on the battlefield and in the civilian sector. OPs exposure inhibits enzyme activity, allowing excess acetylcholine to accumulate. Screening of multiple enzymes is highly desirable because it may provide a comprehensive description of the warrior’s capacity fo ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
No Power Detection and Identification of Nerve Agents
SBC: LYNNTECH INC. Topic: CBD10101Rapid identification of asymmetric warfare modes, including unconventional chemical agents based attacks, is vital to the protection of U.S. armed forces personnel. Existing detection methods use bulky and expensive laboratory equipment to analytically determine the identity and concentration of chemical threats, negating their battlefield use. Colorimetric indicators such as the currently deploye ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
Oligonucleotide Enzyme Surrogate (OnES)
SBC: Accacia International LLC Topic: CBD08108Historically organophosphorus compounds such as insecticides and nerve agents have been susceptible to decomposition by proteinaceous enzymes. Organophosphate hydrolases (OPH) represent a practical method to deactivate such compounds peripherally and on surfaces. However, when such organophosphates are ingested, the use of proteinaceous enzymes such as OPH can be problematic because of their tende ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense -
RNAi screening for Identification of Compounds to Induce Suspended Animation or Hypometabolism
SBC: AGAVE BIOSYSTEMS INC. Topic: N/AWhile the phenomenon of suspended animation has not been widely studied in humans, there are many anecdotal and medically verified examples of humans being in a state that is comparable to suspended animation when they have been accidentally nearly frozenfor short periods of time. There could be many advantages to inducing suspended animation or hypometabolism in humans such as extending survival ...
SBIR Phase I 2003 Department of DefenseOffice for Chemical and Biological Defense -
Carbon Nanotube-Based Filters for Aerosol Sample Collection
SBC: AGAVE BIOSYSTEMS INC. Topic: CBD07111Aerosols represent one of the more efficient methods to distribute biological and chemical agents throughout the atmosphere. Small aerosol droplets can be readily inhaled and easily penetrate deep into the lungs where they lodge in bronchial alveoli. Within the alveoli, chemical and biological agents can breach epithelial and endothelial cell layers and enter the bloodstream, where they cause da ...
SBIR Phase I 2007 Department of DefenseOffice for Chemical and Biological Defense -
Ribozymes for In Vivo Degradation of G-Nerve Agents
SBC: AGAVE BIOSYSTEMS INC. Topic: CBD08108Given the possibility to administer prophylactic doses of protein bioscavengers inactivating OP nerve agents before they reach their acetylcholinesterase target, much attention has been given to proteins such as human butyrylcholinesterase and paraoxonase I. As small nucleic acid catalysts can exhibit triphosphoesterase activities, the identification of new molecules active against nerve agents w ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense